Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking

doi:10.4239/wjd.v14.i11.1672

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2187)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1306

Figures (1-8)

140

Tables (1-2)

200

Sum=1717

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

259

Sum=358

Nov 15, 2023 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Nov 15, 2023; 14(11): 1672-1692
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1672

Full Size Figure Download Figure

Figure 5 Molecular docking. A: Demonstration of docking outcomes between glycyrrhetinic acid (GA) components and core target molecules; B: Presentation of docking results and binding energies between GA components and core target molecules; C: Heat map display of molecular docking binding energy results. GA: Glycyrrhetinic acid.

Citation: Meng FD, Yuan L, Xu DJ, Che MY, Hou SZ, Lu DD, Liu WJ, Nan Y. Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking. World J Diabetes 2023; 14(11): 1672-1692
URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1672.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1672